Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C22H26O5 |
| Molecular Weight | 370.4388 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC2=C(C[C@@H](CO2)C3=C(O)C=C(O)C=C3)C(OC)=C1CC=C(C)C
InChI
InChIKey=DDMAUIOCNQXFHL-AWEZNQCLSA-N
InChI=1S/C22H26O5/c1-13(2)5-7-17-20(25-3)11-21-18(22(17)26-4)9-14(12-27-21)16-8-6-15(23)10-19(16)24/h5-6,8,10-11,14,23-24H,7,9,12H2,1-4H3/t14-/m0/s1
| Molecular Formula | C22H26O5 |
| Molecular Weight | 370.4388 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:55:56 UTC 2023
by
admin
on
Sat Dec 16 09:55:56 UTC 2023
|
| Record UNII |
T6ZF2ZY8CW
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
T6ZF2ZY8CW
Created by
admin on Sat Dec 16 09:55:56 UTC 2023 , Edited by admin on Sat Dec 16 09:55:56 UTC 2023
|
PRIMARY | |||
|
142561-10-2
Created by
admin on Sat Dec 16 09:55:56 UTC 2023 , Edited by admin on Sat Dec 16 09:55:56 UTC 2023
|
PRIMARY | |||
|
480860
Created by
admin on Sat Dec 16 09:55:56 UTC 2023 , Edited by admin on Sat Dec 16 09:55:56 UTC 2023
|
PRIMARY | |||
|
DTXSID80931525
Created by
admin on Sat Dec 16 09:55:56 UTC 2023 , Edited by admin on Sat Dec 16 09:55:56 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
GLYASPERIN D exhibited antimicrobial activity (MICs 3.13?12.5 ug/ml) against MSSAs (strains FDA 209P and Smith) and MRSAs(strains K3 and ST 28).
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
|
